AVITA Medical, Inc. (RCEL)

AVITA Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2021
Revenue	72.4	64.25	50.14	34.42	33.03	29.23
Revenue Growth (YoY)	20.59%	28.14%	45.68%	4.23%	12.98%	104.95%
Cost of Revenue	11.77	9.09	7.78	6.04	6.1	5.95
Gross Profit	60.63	55.16	42.36	28.38	26.92	23.28
Selling, General & Admin	82.72	91.39	65.63	45.24	37.92	37.06
Research & Development	20	20.36	20.82	13.86	15.67	14.82
Other Operating Expenses	-	-	-1.43	-3.22	-1.59	-2.06
Operating Expenses	102.71	111.75	85.02	55.89	52	49.82
Operating Income	-42.08	-56.59	-42.66	-27.51	-25.08	-26.54
Interest Expense	-214.05	-211.36	-776.14	-0.02	-0.03	-0.02
Interest & Investment Income	1.1	2.7	3.1	-	-	-
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.02	-	-	-
Other Non Operating Income (Expenses)	207.25	205.98	773.8	0.89	0.05	0.02
EBT Excluding Unusual Items	-47.81	-59.29	-41.92	-26.63	-25.06	-26.55
Gain (Loss) on Sale of Assets	-	-	9.4	-	-	-
Asset Writedown	-	-	-	-	-0.04	-
Other Unusual Items	-0.7	-2.5	-2.8	-	-	-
Pretax Income	-48.51	-61.79	-35.32	-26.63	-25.1	-26.55
Income Tax Expense	0.05	0.05	0.07	0.04	0.04	0.04
Earnings From Continuing Operations	-48.56	-61.85	-35.38	-26.67	-25.14	-26.58
Net Income	-48.56	-61.85	-35.38	-26.67	-25.14	-26.58
Net Income to Common	-48.56	-61.85	-35.38	-26.67	-25.14	-26.58
Shares Outstanding (Basic)	27	26	25	25	24	23
Shares Outstanding (Diluted)	27	26	25	25	24	23
Shares Change (YoY)	4.20%	2.18%	1.32%	2.64%	7.42%	11.75%
EPS (Basic)	-1.81	-2.39	-1.40	-1.07	-1.03	-1.17
EPS (Diluted)	-1.81	-2.39	-1.40	-1.07	-1.03	-1.17
Free Cash Flow	-37.13	-58.11	-39.39	-19.54	-18.52	-26.8
Free Cash Flow Per Share	-1.39	-2.25	-1.55	-0.78	-0.76	-1.18
Gross Margin	83.74%	85.85%	84.48%	82.45%	81.52%	79.65%
Operating Margin	-58.13%	-88.08%	-85.07%	-79.91%	-75.93%	-90.79%
Profit Margin	-67.06%	-96.25%	-70.56%	-77.47%	-76.13%	-90.94%
Free Cash Flow Margin	-51.28%	-90.44%	-78.56%	-56.77%	-56.09%	-91.66%
EBITDA	-40.03	-55.47	-42.02	-26.94	-24.4	-25.83
EBITDA Margin	-55.28%	-86.33%	-83.81%	-78.26%	-73.89%	-88.34%
D&A For EBITDA	2.06	1.13	0.63	0.57	0.67	0.72
EBIT	-42.08	-56.59	-42.66	-27.51	-25.08	-26.54
EBIT Margin	-58.13%	-88.08%	-85.07%	-79.91%	-75.93%	-90.79%
Revenue as Reported	72.4	64.25	50.14	-	-	-
Advertising Expenses	-	0.54	0.4	0.22	-	0.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q